Diabetes Center at UCSF - Paul Fitzgerald, M.D.

Overview Basic Science Translational Research Clinical Research Islet Transplantation Publications List Training Opportunities Diabetes Research Links The Hormone Research Institute The Metabolic Research Unit

Diabetes Endocrinology Research Center (DERC)

DERC was established to support and enhance interactions among an outstanding team of investigators involved in Type 1 or 2 diabetes research.

UCSF JDRF CENTER (CCCT)

The mission of the center is to develop and test a new approach to the treatment of Type 1 diabetes by bringing together researchers from 5 academic institutions and 1 commercial partner.

Paul Fitzgerald, M.D.

Fitzgerald, PA: Endocrine Disorders. In Current Medical Diagnosis and Treatment 2003 (CMDT 2003) (Tierney, LM, JR, et al, eds.) New York, N.Y.: Lange Medical Books/McGraw Hill, 2003.

Fitzgerald, PA: Hypothalamic and Pituitary Hormones. In Basic and Clinical Pharmacology. (Katzung B., ed) New York, N.Y.: Mc-Graw Hill, 2003.

Fitzgerald, PA, Goldfien, A: The Adrenal Medulla. In Basic and Clinical Endocrinology. (Greenspan, F and Gardner, D, eds.) New York, N.Y.: McGraw-Hill, 2003.

Fitzgerald, PA: Pheochromocytoma and Paraganglioma. In ACS Endocrine Tumors (Clark, OH; Duh, Q; Perrier, N; Jahan, T, eds.) Hamilton, ON, Canada, 2003.

Rose, B, Matthay, KK, Price D, Huberty J, Klencke B, Norton JA, Fitzgerald, PA: High-dose 131I-Metaiodobenzylguanadine (MIBG) therapy for 12 patients with malignant pheochromocytoma. Cancer 98:July 2003.